Medications

First biosimilar approved to treat multiple sclerosis

The U.S. Food and Drug Administration approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection, for the treatment of relapsing forms of multiple sclerosis, the agency announced Thursday.

Diseases, Conditions, Syndromes

Pattern of disc degeneration impacts low back pain

(HealthDay) -- Contiguous, multilevel disc degeneration (CMDD) is associated with increased likelihood of low back pain (LBP) and pain severity compared with skipped level disc degeneration (SLDD), according to a study published ...

Psychology & Psychiatry

How to recognize early learning challenges in kids

(HealthDay)—Many children have difficulty with learning at some point, but those with learning disabilities often have several specific and persistent signs, which can start in preschool years. Recognizing them as soon ...

Medications

The drugs don't work

(Medical Xpress)—Drugs that do not represent value for money or are medically unproven may be increasingly reaching one of Europe's largest pharmaceutical markets, according to research undertaken by Cambridge sociologist ...

Cardiology

Best practices developed for diagnosing, managing MINOCA

(HealthDay)—In an American Heart Association scientific statement published online March 27 in Circulation, best practices are presented for diagnostic evaluation and management of myocardial infarction in the absence of ...

page 5 from 19